Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicol Mech Methods ; 27(7): 518-527, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28552037

RESUMO

DON (6-diazo-5-oxo-l-norleucine), a glutamine antagonist, was demonstrated to exhibit analgesic, antibacterial, antiviral and anticancer properties. The study was performed to characterize its in vitro and in vivo genetic toxicity potential. DON was tested in the bacterial reverse mutation assay (Ames test) using Salmonella typhimurium tester strains (TA98, TA100, TA1535 and TA1537) and Escherichia coli tester strain (WP2 uvrA) with and without S9 and also with reductive S9. In addition, DON was tested for the chromosome aberrations in Chinese hamster ovary (CHO) cells with or without S9 to evaluate the clastogenic potential. Furthermore, DON was also evaluated for its in vivo clastogenic activity by detecting micronuclei in polychromatic erythrocyte (PCE) cells in bone marrow collected from the male mice dosed intravenously with 500, 100, 10, 1 and 0.1 mg/kg at 24 and 48-h post-dose. The Ames mutagenicity assay showed no positive mutagenic responses. However, the in vitro chromosome aberration assay demonstrated dose dependent statistically positive increase in structural aberrations at 4 and 20-h exposure without S9 and also at 4-h exposure with S9. The in vivo micronucleus assay also revealed a statistically positive response for micronucleus formation at 500, 100 and 10 mg/kg at 24 and 48-h post-dose. Thus, DON appears to be negative in the Ames test but positive in the in vitro chromosome aberration assay and in the in vivo micronucleus assay. In conclusion, the results indicate DON is a genotoxic compound with a plausible epigenetic mechanism.


Assuntos
Compostos Azo/toxicidade , Aberrações Cromossômicas/efeitos dos fármacos , Células Precursoras Eritroides/efeitos dos fármacos , Glutamina/antagonistas & inibidores , Mutagênicos/toxicidade , Neurotransmissores/toxicidade , Norleucina/análogos & derivados , Ativação Metabólica , Animais , Arocloros/farmacologia , Compostos Azo/administração & dosagem , Compostos Azo/metabolismo , Células CHO , Cricetinae , Cricetulus , Relação Dose-Resposta a Droga , Poluentes Ambientais/farmacologia , Masculino , Mesocricetus , Camundongos Endogâmicos ICR , Testes para Micronúcleos , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Microssomos Hepáticos/metabolismo , Testes de Mutagenicidade , Mutagênicos/administração & dosagem , Mutagênicos/metabolismo , Neurotransmissores/administração & dosagem , Neurotransmissores/metabolismo , Norleucina/administração & dosagem , Norleucina/metabolismo , Norleucina/toxicidade , Ratos Sprague-Dawley , Testes de Toxicidade Aguda
2.
Transgenic Res ; 21(2): 257-63, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21656205

RESUMO

Our laboratory is conducting experiments designed to characterize the role of p53 in gene expression in the TSG-p53® mouse model. In the study reported here, gene expression levels in tissue derived from the testis, liver, and heart of male, 8-9 week old, p53 wild-type (WT), heterozygous (HET) or knockout (KO) mice were determined utilizing a targeted qPCR 84-gene array. The heart, liver and testis were selected because of the unique function and rate of cell division of each tissue. The genes on the arrays were categorized into three Functional Gene Groups, Apoptosis, Cell-Cycle and DNA Repair. Differences in expression of the functional groups were determined by multivariate analysis of variance (MANOVA) and significant (P < 0.05) differences in their expression were found among the heart, liver and testis. Further, the expression of the Functional Gene Groups in each of these tissues was also significantly affected by p53 genotype. These data indicate that gene expression in unperturbed tissue is influenced by the status of p53 genotype, and relates, at least partially, to the function of the tissue.


Assuntos
Regulação da Expressão Gênica , Fígado/metabolismo , Miocárdio/metabolismo , Testículo/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Animais , Apoptose , Pontos de Checagem do Ciclo Celular , Divisão Celular , Reparo do DNA , Perfilação da Expressão Gênica , Genes p53 , Heterozigoto , Fígado/citologia , Fígado/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Análise Multivariada , Miocárdio/citologia , Estresse Oxidativo , Reação em Cadeia da Polimerase/métodos , RNA/genética , RNA/metabolismo , Testículo/citologia , Testículo/fisiologia , Proteína Supressora de Tumor p53/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA